Michael Berelowitz, Director at Recro Pharma, Inc. (REPH), sold 7,500 shares at $10.45 ($78K) on 2018-03-09, disclosed to the SEC on 2018-03-13.
Open-market sale of $78k REPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ORMP | SELL | 2014-04-02 | $99K | — | Filing → |